Bristol-Myers Squibb Company (BMY)
Bristol-Myers Squibb Company Dividend Yield: 4.04%
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
BMY Dividend Yield Rankings
| Overall | 88th percentile | 552 of 4658 |
| Sector | 97th percentile | 13 of 526 in Healthcare |
| Industry | 74th percentile | 7 of 27 in Drug Manufacturers - Major |
BMY Dividend Yield Range, Past 5 Years
| Minimum | 2.96% | Mar 2012 |
| Maximum | 8.90% | Jun 2010 |
| Average | 5.36% |
About Dividend Yield
The dividend yield is the sum company's annual dividends per share, divided by the current price per share. It is often expressed as a percentage. It the reciprocal of the price/dividend ratio. By investing in a company with a high dividend yield, investors can secure a relatively stable cash flow. However, it is important to note that sometimes dividend yields are high when a company is facing financial trouble, and the company may cut the dividend in the near future.
For example, if a stock trades at $36 and pays $1.80 in dividends over the course of one year ($.45 per quarter), the company's dividend yield is 5%.
Learn More
You may also be interested in these BMY related companies
BMY News
RT @ianestepan $CLDX if this data was from $BMY,$ONXX,$MDVN,$DNA or $PFE - people would be soooooo excited....
about a day ago by N0M0NEY_N0H0NEY
about a day ago by N0M0NEY_N0H0NEY
News related to $BMY, currently +0.5% since open: 'Bristol-Myers says FDA clears Mass. plant' http://stks.co/3q1B
about 10 days ago by TradeBot
about 10 days ago by TradeBot
Six Suitors Join $BMY in Considering a Bid for $AMLN http://stks.co/3psG
about 10 days ago by abubnic
about 10 days ago by abubnic
The Drama Continues At $AMLN: Takeover Still Likely. $BMY $LLY $SNY http://stks.co/3prL
about 10 days ago by abubnic
about 10 days ago by abubnic
Bristol-Myers (BMY) Announces FDA Approval of Devens, MA Plant for Manufacture of ORENCIA
May 15, 11:17AM Street Insider
May 15, 11:17AM Street Insider
U.S. FDA Approves Bristol-Myers Squibb Devens Biologics Manufacturing Facility
May 15, 11:01AM Benzinga
May 15, 11:01AM Benzinga
U.S. FDA Approves Bristol-Myers Squibb Devens Biologics Manufacturing Facility for Production of ORENCIA® (abatacept)
May 15, 11:00AM Business Wire
May 15, 11:00AM Business Wire
NR7 (EOD): Potential bullish NR7. Entry: 33.31. First Target: 34.00. $BMY http://chart.ly/qwxxeih
about 12 days ago by jackdamn
about 12 days ago by jackdamn
$BMY Ipilimumab,also known as MDX-010 or MDX-101 $DNDN Provenge along with $ARNA and $VVUS have been and are my Phamas for the next yr
about 14 days ago by selectstock
about 14 days ago by selectstock
Bristol-Myers Squibb to Present at Bank of America Merrill Lynch Health Care Conference
May 10, 11:00AM Business Wire
May 10, 11:00AM Business Wire
Huf Post: Two Drugs Harness Immune System To Fight Cancer. http://stks.co/3iDa $DNDN $BMY $AZN $ONTY $GSK
about 17 days ago by abubnic
about 17 days ago by abubnic
Listen to $BMY Bristol-Myers Squibb at Deutsche Bank AG Health Care Conference - live at 10:40 AM, ondemand after - http://stks.co/3hTs
about 18 days ago by earningscast
about 18 days ago by earningscast
@russwm thanks working hard here. above 34 is a desc trend break + above 10day. needs to hold 50day $BMY http://chart.ly/mghypbo
about 23 days ago by TraderNewburgh
about 23 days ago by TraderNewburgh
@TraderNewburgh I would love to hear your thoughts on $BMY in the short/medium term, if you have the time. Love your videos.
about 23 days ago by russwm
about 23 days ago by russwm
Listen to $BMY Bristol-Myers Squibb Annual Meeting of Stockholders - live at 10:00 AM, ondemand after - http://stks.co/3bIu
about 24 days ago by earningscast
about 24 days ago by earningscast
http://stks.co/3XIO Health Care Report Take A Look $FURX $BMY $AMLN
about 29 days ago by Stockmarketman2
about 29 days ago by Stockmarketman2
Listen to $BMY Q1 2012 earnings call - live at 10:30 AM, ondemand after - http://stks.co/3WpX
about 29 days ago by earningscast
about 29 days ago by earningscast
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| BMY | 32.99 | +0.47 | +1.45% | 54.88B |
| BMTI | 2.41 | +0.10 | +4.33% | 64.98M |
| BMRN | 38.51 | +0.47 | +1.24% | 4.398B |
| BMR | 18.42 | +0.05 | +0.27% | 2.833B |
| BLTI | 2.37 | +0.01 | +0.42% | 72.43M |
| BLL | 39.86 | +0.33 | +0.83% | 6.180B |
| BKSC | 11.37 | -0.63 | -5.25% | 50.60M |
| BKR | 22.62 | +0.09 | +0.40% | 214.94M |
| BKMU | 3.52 | +0.03 | +0.86% | 161.69M |
| BKK | 16.22 | +0.12 | +0.75% |